Results of Medical Research Council phase II study of low dose cisplatin and methotrexate in the primary treatment of locally advanced (T3 and T4) transitional cell carcinoma of the bladder.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples